# Safety Study of a Refrigerator-stable Formulation of VARIVAX®

> **NCT00432731** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 500 (—)

## Conditions studied

- Varicella
- Measles
- Mumps
- Rubella

## Interventions

- **BIOLOGICAL:** VARIVAX®
- **BIOLOGICAL:** M-M-RTM II

## Key facts

- **NCT ID:** NCT00432731
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 500 (—)
- **Last updated:** 2017-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432731, "Safety Study of a Refrigerator-stable Formulation of VARIVAX®". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00432731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*